Altimmune to Present at Upcoming Investor Conferences
- Stifel’s 2021
Virtual Healthcare Conference Monday, November 15, 2021 10:40 am Eastern Time Jefferies London Healthcare Conference Thursday, November 18, 2021 8:00 am GMT
The sessions will be webcast and can be accessed by visiting the Events section of the Altimmune website.
Altimmune is a clinical stage biopharmaceutical company focused on developing treatments for obesity and liver diseases. Our pipeline includes next generation peptide therapeutics for obesity, NASH (pemvidutide), and chronic hepatitis B (HepTcell™). For more information, please visit www.altimmune.com.
Altimmune Investor & Media Contact:
Chief Financial Officer
Source: Altimmune, Inc